TCMP
PODD icon

Thrive Capital Management (Pennsylvania)’s Insulet PODD Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.46M Buy
29,292
+14,395
+97% +$2.4M 0.84% 50
2026
Q1 		$3.13M Buy
14,897
+3,372
+29% +$847K 0.69% 73
2025
Q4 		$3.28M Buy
11,525
+4,630
+67% +$1.45M 0.73% 72
2025
Q3 		$2.13M Buy
6,895
+983
+17% +$308K 0.55% 81
2025
Q2 		$1.86M Buy
5,912
+3,677
+165% +$1.06M 0.58% 77
2025
Q1 		$587K Buy
+2,235
New +$605K 0.35% 63

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s PODD Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) increased its Insulet (PODD) stake by 97% in Q2 2026, buying an estimated $2.4M and bringing the position to 29,292 shares worth $4.46M. The position accounts for 0.84% of the portfolio, ranked #50.

Thrive Capital Management (Pennsylvania) first reported a position in PODD in Q1 2025 and has held it in 6 quarters since. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 29,292 shares of Insulet worth $4.46M as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) bought 14,395 Insulet shares in Q2 2026, an estimated $2.4M.
  • Insulet made up 0.84% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #50 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Insulet in Q1 2025 and has held it in 6 quarters since.
  • 731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.